UiPath (NYSE:PATH) Trading Up 1.2%

UiPath Inc. (NYSE:PATH) was up 1.2% on Friday . The stock traded as high as $13.16 and last traded at $13.12. Approximately 1,948,078 shares changed hands during mid-day trading, a decline of 80% from the average daily volume of 9,817,967 shares. The stock had previously closed at $12.96.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on PATH shares. JPMorgan Chase & Co. reduced their price target on UiPath from $28.00 to $19.00 and set an “overweight” rating on the stock in a report on Thursday, May 30th. Macquarie downgraded UiPath from an “outperform” rating to a “neutral” rating and reduced their price objective for the stock from $29.00 to $12.00 in a report on Monday, June 3rd. Mizuho reduced their price objective on UiPath from $25.00 to $14.00 and set a “neutral” rating on the stock in a report on Thursday, May 30th. Scotiabank reduced their price objective on UiPath from $30.00 to $25.00 and set a “sector perform” rating on the stock in a report on Wednesday, May 29th. Finally, Morgan Stanley reduced their price objective on UiPath from $25.00 to $15.00 and set an “equal weight” rating on the stock in a report on Thursday, May 30th. Sixteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, UiPath has an average rating of “Hold” and an average target price of $18.06.

UiPath Trading Up 1.8 %

The stock has a market cap of $7.55 billion, a price-to-earnings ratio of -82.00 and a beta of 0.86. The stock has a 50-day moving average price of $15.66 and a two-hundred day moving average price of $20.47.

UiPath (NYSE:PATH) last posted its quarterly earnings data on Wednesday, May 29th. The healthcare company reported ($0.03) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.03). The firm had revenue of $335.11 million during the quarter, compared to analysts’ expectations of $332.84 million. UiPath had a negative return on equity of 2.97% and a negative net margin of 6.41%. Research analysts predict that UiPath Inc. will post -0.2 earnings per share for the current fiscal year.

Insider Transactions at UiPath

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of UiPath stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $19.79, for a total transaction of $791,600.00. Following the completion of the sale, the chief financial officer now owns 946,848 shares of the company’s stock, valued at approximately $18,738,121.92. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 22.37% of the company’s stock.

Institutional Trading of UiPath

A number of institutional investors and hedge funds have recently added to or reduced their stakes in PATH. Mark Sheptoff Financial Planning LLC purchased a new position in shares of UiPath during the 4th quarter valued at about $25,000. HighMark Wealth Management LLC purchased a new position in shares of UiPath during the 4th quarter valued at about $27,000. Cypress Capital Management LLC WY purchased a new position in shares of UiPath during the 4th quarter valued at about $29,000. ORG Partners LLC raised its stake in shares of UiPath by 875.6% during the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after buying an additional 1,112 shares during the last quarter. Finally, GAMMA Investing LLC purchased a new position in shares of UiPath in the 4th quarter valued at about $36,000. Institutional investors and hedge funds own 62.50% of the company’s stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.